J E Potter1, S McKinley, A Delaney. 1. NSW Organ and Tissue Donation Service, South Eastern Sydney Local Health District, PO Box 486, Kogarah, NSW 1485, Australia. julespot1@gmail.com
Abstract
PURPOSE:Critically ill patients are often unable to give informed consent to participate in clinical research. A process of delayed consent, enrolling patients into clinical trials and obtaining consent as soon as practical from either the participant or their substitute decision maker, has sometimes been used. The objective of this study was to determine the opinion of participants, previously enrolled in the NICE-SUGAR study, of the delayed consent process. METHODS: This observational study was conducted from 2009 to 2010 in the ICU of a tertiary referral hospital in Australia. Participants who were enrolled in the NICE-SUGAR study with delayed consent who survived, were cognitively intact, and proficient in English were posted a questionnaire regarding their opinion of the delayed consent process. The questionnaire was returned by post, fax, email, or completed during a telephone interview. RESULTS: Of 298 eligible participants, 210 responded, with an overall response rate of 79 %. Delayed consent to participate in the NICE-SUGAR study was obtained from participants (57/210; 27.1 %) or the substitute decision maker (152/210; 72.4 %). Most respondents (195/204; 95.6 %) would have consented to participate in the NICE-SUGAR study if asked before enrolment; most (163/198; 82.3 %) ranked first "the person who consented on their behalf for the NICE Study" as most preferred to make decisions, should they be unable; and most (177/202; 87.6 %) agreed with the decision made by their relative. CONCLUSION: Delayed consent to participate in a clinical trial that includes critically ill patients is acceptable from research participant's perspectives.
RCT Entities:
PURPOSE:Critically illpatients are often unable to give informed consent to participate in clinical research. A process of delayed consent, enrolling patients into clinical trials and obtaining consent as soon as practical from either the participant or their substitute decision maker, has sometimes been used. The objective of this study was to determine the opinion of participants, previously enrolled in the NICE-SUGAR study, of the delayed consent process. METHODS: This observational study was conducted from 2009 to 2010 in the ICU of a tertiary referral hospital in Australia. Participants who were enrolled in the NICE-SUGAR study with delayed consent who survived, were cognitively intact, and proficient in English were posted a questionnaire regarding their opinion of the delayed consent process. The questionnaire was returned by post, fax, email, or completed during a telephone interview. RESULTS: Of 298 eligible participants, 210 responded, with an overall response rate of 79 %. Delayed consent to participate in the NICE-SUGAR study was obtained from participants (57/210; 27.1 %) or the substitute decision maker (152/210; 72.4 %). Most respondents (195/204; 95.6 %) would have consented to participate in the NICE-SUGAR study if asked before enrolment; most (163/198; 82.3 %) ranked first "the person who consented on their behalf for the NICE Study" as most preferred to make decisions, should they be unable; and most (177/202; 87.6 %) agreed with the decision made by their relative. CONCLUSION: Delayed consent to participate in a clinical trial that includes critically illpatients is acceptable from research participant's perspectives.
Authors: Sangeeta Mehta; Friederike Quittnat Pelletier; Maedean Brown; Cheryl Ethier; David Wells; Lisa Burry; Rod MacDonald Journal: Intensive Care Med Date: 2011-11-26 Impact factor: 17.440
Authors: Simon Finfer; Dean R Chittock; Steve Yu-Shuo Su; Deborah Blair; Denise Foster; Vinay Dhingra; Rinaldo Bellomo; Deborah Cook; Peter Dodek; William R Henderson; Paul C Hébert; Stephane Heritier; Daren K Heyland; Colin McArthur; Ellen McDonald; Imogen Mitchell; John A Myburgh; Robyn Norton; Julie Potter; Bruce G Robinson; Juan J Ronco Journal: N Engl J Med Date: 2009-03-24 Impact factor: 91.245
Authors: Colin R Cooke; Sara E Erickson; Timothy R Watkins; Michael A Matthay; Leonard D Hudson; Gordon D Rubenfeld Journal: Crit Care Med Date: 2010-06 Impact factor: 7.598
Authors: Karen E A Burns; Nora M Magyarody; Mark Duffett; Rosane Nisenbaum; Deborah J Cook Journal: Am J Crit Care Date: 2010-04-08 Impact factor: 2.228
Authors: F Pochard; E Azoulay; S Chevret; F Lemaire; P Hubert; P Canoui; M Grassin; R Zittoun; J R le Gall; J F Dhainaut; B Schlemmer Journal: Crit Care Med Date: 2001-10 Impact factor: 7.598
Authors: Jennifer L McAdam; Kathleen A Dracup; Douglas B White; Dorothy K Fontaine; Kathleen A Puntillo Journal: Crit Care Med Date: 2010-04 Impact factor: 7.598
Authors: Elie Azoulay; Giuseppe Citerio; Jan Bakker; Matteo Bassetti; Dominique Benoit; Maurizio Cecconi; J Randall Curtis; Glenn Hernandez; Margaret Herridge; Samir Jaber; Michael Joannidis; Laurent Papazian; Mark Peters; Pierre Singer; Martin Smith; Marcio Soares; Antoni Torres; Antoine Vieillard-Baron; Jean-François Timsit Journal: Intensive Care Med Date: 2014-01-24 Impact factor: 17.440
Authors: Louisa W Whitesides; Jill M Baren; Michelle H Biros; Ross J Fleischman; Prasanthi R Govindarajan; Elizabeth B Jones; Arthur M Pancioli; Rebecca D Pentz; Victoria M Scicluna; David W Wright; Neal W Dickert Journal: Clin Trials Date: 2016-11-15 Impact factor: 2.486
Authors: Neal W Dickert; Victoria M Scicluna; Jill M Baren; Michelle H Biros; Ross J Fleischman; Prasanthi R Govindarajan; Elizabeth B Jones; Arthur M Pancioli; David W Wright; Rebecca D Pentz Journal: Crit Care Med Date: 2015-03 Impact factor: 7.598
Authors: Jane Topolovec-Vranic; Marlene Santos; Andrew J Baker; Orla M Smith; Karen E A Burns Journal: Can Respir J Date: 2014-06-10 Impact factor: 2.409
Authors: Neal W Dickert; Victoria A Mah; Michelle H Biros; Deneil M Harney; Robert Silbergleit; Jeremy Sugarman; Emir Veledar; Kevin P Weinfurt; David W Wright; Rebecca D Pentz Journal: Crit Care Med Date: 2014-02 Impact factor: 7.598
Authors: Nina H Gobat; Micaela Gal; Nick A Francis; Kerenza Hood; Angela Watkins; Jill Turner; Ronald Moore; Steve A R Webb; Christopher C Butler; Alistair Nichol Journal: Trials Date: 2015-12-29 Impact factor: 2.279